Page last updated: 2024-08-23

idazoxan and Cirrhosis, Liver

idazoxan has been researched along with Cirrhosis, Liver in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hao, C; Jianping, G; Xuanfei, L; Yanming, L; Zhujun, Y	1

Other Studies

1 other study(ies) available for idazoxan and Cirrhosis, Liver

Article	Year
Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway. Oncotarget, 2017, Mar-28, Volume: 8, Issue:13 Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Carbon Tetrachloride; Cell Proliferation; Hepatic Stellate Cells; Humans; Idazoxan; Imidazoline Receptors; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad2 Protein; Smad3 Protein; Tumor Cells, Cultured	2017

Article

Year

Imidazoline I2 receptor inhibitor idazoxan regulates the progression of hepatic fibrosis via Akt-Nrf2-Smad2/3 signaling pathway.

Oncotarget, 2017, Mar-28, Volume: 8, Issue:13

Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Apoptosis; Carbon Tetrachloride; Cell Proliferation; Hepatic Stellate Cells; Humans; Idazoxan; Imidazoline Receptors; Liver Cirrhosis; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-E2-Related Factor 2; Oxidative Stress; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad2 Protein; Smad3 Protein; Tumor Cells, Cultured

2017